(Q54534916)

English

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. (English)

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

0 references

0 references

Pneumocystis jirovecii

object named as

Pneumocystis jirovecii

1 reference

based on heuristic

inferred from title

Philippe M Hauser

object named as

Philippe M Hauser

7

0 references

object named as

Olga Matos

11

0 references

J Peter Donnelly

object named as

J Peter Donnelly

5

0 references

object named as

Simone Cesaro

2

0 references

Hermann Einsele

4

object named as

Hermann Einsele

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

13

object named as

Johan Maertens

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Alexandre Alanio

6

object named as

Alexandre Alanio

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

8

object named as

Katrien Lagrou

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Willem Melchers

9

object named as

Willem J G Melchers

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Jannik Helweg-Larsen

10

object named as

Jannik Helweg-Larsen

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Georg Maschmeyer

3

object named as

Georg Maschmeyer

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Stéphane Bretagne

12

object named as

Stéphane Bretagne

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

author name string

Catherine Cordonnier

1

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Fifth European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN)

14

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

language of work or name

0 references

publication date

12 May 2016

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

71

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

2379-2385

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

9

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Pneumocystis carinii pneumonitis in children with malignancies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Increasing Pneumocystis pneumonia, England, UK, 2000-2010

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Infections in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis jirovecii pneumonia in non-HIV infected patients: a study of 41 cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Dectin immunoadhesins and pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis pneumonia in patients treated with rituximab

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in patients without AIDS.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis pneumonia in children

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Clinical conditions associated with PCP in children.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Analysis of clinical features of non-HIV Pneumocystis jirovecii pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Differences and similarities of cytomegalovirus and pneumocystis pneumonia in HIV-negative immunocompromised patients thin section CT morphology in the early phase of the disease.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Radiological features of Pneumocystis jirovecii Pneumonia in immunocompromised patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Pneumocystis jiroveci pneumonia detected by FDG-PET.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

The changing face of Pneumocystis carinii pneumonia in AIDS patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Reversed halo sign on computed tomography: state-of-the-art review

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Reversed halo sign in pneumocystis pneumonia: a case report

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

FDG-PET imaging in Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

A diagnostic challenge: PCP in a non-HIV patient.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW155

21 January 2018

Identifiers

10.1093/JAC/DKW155

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/27550990

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54534916&oldid=1857505454"